GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
TBCIX
Price
$190.01
Change
-$4.75 (-2.44%)
Updated
Feb 21 closing price
Net Assets
64.04B
Ad is loading...

GFACX vs TBCIX

Header iconGFACX vs TBCIX Comparison
Open Charts GFACX vs TBCIXBanner chart's image
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
T. Rowe Price Blue Chip Growth I
Price$190.01
Change-$4.75 (-2.44%)
VolumeN/A
Net Assets64.04B
GFACX vs TBCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. TBCIX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and TBCIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. TBCIX (64B). GFACX (0.00) and TBCIX (0.00) have matching dividends . GFACX was incepted earlier than TBCIX: GFACX (24 years) vs TBCIX (9 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. TBCIX (9.80). GFACX has a lower initial minimum investment than TBCIX: GFACX (250) vs TBCIX (500000). TBCIX annual gain was more profitable for investors over the last year : 13.14 vs. GFACX (10.15). TBCIX return over 5 years is better than : 42.49 vs. GFACX (32.83).
GFACXTBCIXGFACX / TBCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years9 years-
Gain YTD2.9801.398213%
Front LoadN/AN/A-
Min. Initial Investment2505000000%
Min. Initial Investment IRAN/AN/A-
Net Assets304B64B475%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.1513.1477%
Returns for 3 years17.6929.4860%
Returns for 5 years32.8342.4977%
Returns for 10 years55.63N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding